UK markets closed

Square, Inc. (SQ)

NYSE - NYSE Delayed price. Currency in USD
Add to watchlist
62.97+0.23 (+0.37%)
At close: 04:00PM EDT
63.09 +0.12 (+0.19%)
After hours: 07:59PM EDT
Currency in USD

Valuation measures4

Market cap (intra-day) 38.86B
Enterprise value 33.85B
Trailing P/E 104.57
Forward P/E 18.87
PEG ratio (5-yr expected) 0.69
Price/sales (ttm)1.69
Price/book (mrq)2.04
Enterprise value/revenue 1.47
Enterprise value/EBITDA 30.97

Trading information

Stock price history

Beta (5Y monthly) 2.54
52-week change 31.98%
S&P500 52-week change 326.24%
52-week high 387.52
52-week low 338.85
50-day moving average 369.17
200-day moving average 364.80

Share statistics

Avg vol (3-month) 37.78M
Avg vol (10-day) 36.85M
Shares outstanding 5556.55M
Implied shares outstanding 6617.04M
Float 8553.31M
% held by insiders 10.84%
% held by institutions 170.18%
Shares short (15 May 2024) 410.73M
Short ratio (15 May 2024) 41.23
Short % of float (15 May 2024) 41.94%
Short % of shares outstanding (15 May 2024) 41.74%
Shares short (prior month 15 Apr 2024) 412.59M

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 2N/A
Last split date 3N/A

Financial highlights

Fiscal year

Fiscal year ends 31 Dec 2023
Most-recent quarter (mrq)31 Mar 2024


Profit margin 1.68%
Operating margin (ttm)4.19%

Management effectiveness

Return on assets (ttm)0.33%
Return on equity (ttm)1.94%

Income statement

Revenue (ttm)22.88B
Revenue per share (ttm)37.37
Quarterly revenue growth (yoy)19.40%
Gross profit (ttm)N/A
EBITDA 515.49M
Net income avi to common (ttm)383.46M
Diluted EPS (ttm)0.60
Quarterly earnings growth (yoy)380.10%

Balance sheet

Total cash (mrq)6.37B
Total cash per share (mrq)10.32
Total debt (mrq)5.41B
Total debt/equity (mrq)28.53%
Current ratio (mrq)1.64
Book value per share (mrq)30.74

Cash flow statement

Operating cash flow (ttm)295.96M
Levered free cash flow (ttm)396.34M